ACAD
47.585
-0.605
-1.255%
AEMD
9.83
+0.33
+3.4726%
APRI
1.37
-0.01
-0.72%
ARNA
4
-0.06
-1.48%
ATEC
1.354
-0.007
-0.4779%
CNAT
4.42
-0.07
-1.56%
CRXM
0.3
0.00
0.00%
CYTX
0.412
-0.014
-3.3529%
DXCM
85.24
+0.71
+0.84%
GNMK
8.04
0.00
0.00%
HALO
23.24
+0.21
+0.91%
ILMN
215.39
-1.31
-0.60%
INNV
0.158
+0.003
+1.935%
INO
7.17
-0.08
-1.10%
ISCO
0.043
0.00
0.00%
ISIS
55.13
+1.17
+2.17%
LGND
109
+0.26
+0.24%
LPTN
0.251
-0.013
-4.9186%
MBVX
1.91
-0.1
-4.98%
MEIP
1.53
+0.04
+2.68%
MNOV
3.6
-0.13
-3.49%
MRTX
27.87
-0.09
-0.32%
MSTX
0.421
-0.009
-2.0921%
NBIX
48.8
-0.19
-0.39%
NUVA
55.76
+0.57
+1.03%
ONCS
5.81
-0.17
-2.8445%
ONVO
3.17
-0.18
-5.37%
OREX
3.91
-0.05
-1.26%
OTIC
25.625
-0.345
-1.328%
QDEL
20.82
+0.2
+0.97%
RCPT
228
-0.56
-0.25%
RGLS
8
+0.01
+0.13%
RMD
55.64
+0.24
+0.43%
SCIE
0.016
-0.002
-10.5555%
SPHS
0.84
0.00
-0.47%
SRNE
20.76
-0.41
-1.94%
TROV
7.41
-0.47
-5.96%
VICL
0.64
+0.01
+1.91%
ZGNX
19.61
+0.01
+0.05%
ACAD
47.585
-0.605
-1.255%
AEMD
9.83
+0.33
+3.4726%
APRI
1.37
-0.01
-0.72%
ARNA
4
-0.06
-1.48%
ATEC
1.354
-0.007
-0.4779%
CNAT
4.42
-0.07
-1.56%
CRXM
0.3
0.00
0.00%
CYTX
0.412
-0.014
-3.3529%
DXCM
85.24
+0.71
+0.84%
GNMK
8.04
0.00
0.00%
HALO
23.24
+0.21
+0.91%
ILMN
215.39
-1.31
-0.60%
INNV
0.158
+0.003
+1.935%
INO
7.17
-0.08
-1.10%
ISCO
0.043
0.00
0.00%
ISIS
55.13
+1.17
+2.17%
LGND
109
+0.26
+0.24%
LPTN
0.251
-0.013
-4.9186%
MBVX
1.91
-0.1
-4.98%
MEIP
1.53
+0.04
+2.68%
MNOV
3.6
-0.13
-3.49%
MRTX
27.87
-0.09
-0.32%
MSTX
0.421
-0.009
-2.0921%
NBIX
48.8
-0.19
-0.39%
NUVA
55.76
+0.57
+1.03%
ONCS
5.81
-0.17
-2.8445%
ONVO
3.17
-0.18
-5.37%
OREX
3.91
-0.05
-1.26%
OTIC
25.625
-0.345
-1.328%
QDEL
20.82
+0.2
+0.97%
RCPT
228
-0.56
-0.25%
RGLS
8
+0.01
+0.13%
RMD
55.64
+0.24
+0.43%
SCIE
0.016
-0.002
-10.5555%
SPHS
0.84
0.00
-0.47%
SRNE
20.76
-0.41
-1.94%
TROV
7.41
-0.47
-5.96%
VICL
0.64
+0.01
+1.91%
ZGNX
19.61
+0.01
+0.05%
Home » Archive by Category

Xconomy

Coelacanths And Other IPO Thoughts Before The Autumn Markets Return

August 26, 2014 – 6:48 am

Ah, the final week of summer. Would that it could go on forever. And thanks for reading this on your mobile device with your toes in the sand. Just don’t forget to take a dip or toss a Frisbee…

[[Click headline to continue reading.]]

Coelacanths And Other IPO Thoughts Before The Autumn Markets Return

August 26, 2014 – 6:48 am

Ah, the final week of summer. Would that it could go on forever. And thanks for reading this on your mobile device with your toes in the sand. Just don’t forget to take a dip or toss a Frisbee…

[[Click headline to continue reading.]]

Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis?

August 25, 2014 – 7:03 am

Swiss pharmaceutical giant Roche said Sunday it would buy Intermune (NASDAQ: ITMN) of Brisbane, CA, for $8.3 billion. It’s by far the high water mark of a growing wave in recent years of deals…

[[Click headline to continue reading.]]

Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis?

August 25, 2014 – 7:03 am

Swiss pharmaceutical giant Roche said Sunday it would buy Intermune (NASDAQ: ITMN) of Brisbane, CA, for $8.3 billion. It’s by far the high water mark of a growing wave in recent years of deals…

[[Click headline to continue reading.]]

BioKier Takes a Shot at a New Kind of Diabetes Drug

August 25, 2014 – 4:00 am

Diabetics know all too well that needle sticks are a routine part of managing their disease. Insulin injections have been part of the diabetes standard of care for decades. And in recent years, a new…

[[Click headline to continue reading.]]

BioKier Takes a Shot at a New Kind of Diabetes Drug

August 25, 2014 – 4:00 am

Diabetics know all too well that needle sticks are a routine part of managing their disease. Insulin injections have been part of the diabetes standard of care for decades. And in recent years, a new…

[[Click headline to continue reading.]]

Biotech Unveils Drug for Viral Infections Tied to Cervical Cancer

August 22, 2014 – 4:00 am

A small San Diego biotech has identified a drug that appears to prevent several subtypes of the human papillomavirus (HPV) from replicating—including the two HPV subtypes that cause 70 percent…

[[Click headline to continue reading.]]

Biotech Unveils Drug for Viral Infections Tied to Cervical Cancer

August 22, 2014 – 4:00 am

A small San Diego biotech has identified a drug that appears to prevent several subtypes of the human papillomavirus (HPV) from replicating—including the two HPV subtypes that cause 70 percent…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Ebola, Mapp, Tekmira, ViaCyte & More

August 21, 2014 – 11:09 am

Big news this morning: two Americans treated with an experimental Ebola treatment have recovered and are now out of the hospital. (A third person, a Spaniard, who received the treatment unfortunately…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Ebola, Mapp, Tekmira, ViaCyte & More

August 21, 2014 – 11:09 am

Big news this morning: two Americans treated with an experimental Ebola treatment have recovered and are now out of the hospital. (A third person, a Spaniard, who received the treatment unfortunately…

[[Click headline to continue reading.]]